DPC Report Card on Medigap Coverage for
ESRD Patients Under 65 Years of Age
- All States
- Grade: A (8)
- Grade: B (9)
- Grade: C (16)
- Grade: D (15)
- Grade: F (4)
DPC Grades Based on Patient Access & Affordability:
A State requires all/most plans to be offered and affordable to ESRD patients under 65.
B State requires some plans to be offered and affordable to ESRD patients under 65. C State requires some plans to be offered, but they are not affordable to most ESRD patients under 65. D State does not require coverage. Some plans are offered, but they are not affordable to most ESRD patients under 65. F State excludes coverage. Some plans may be offered, but they are not affordable to most ESRD patients under 65.Medigap Coverage
While Original Medicare covers 80% of medical costs for eligible beneficiaries, those without any type of supplemental insurance policy – such as Medigap or employer-sponsored secondary insurance – individuals must pay the remaining 20% co-insurance, co-pays and deductibles on their own. Since original Medicare has no annual cap for the 20% out-of-pocket co-insurance expenses, this can cause serious financial strain for many Medicare beneficiaries. Some End Stage Renal Disease (ESRD) patients under age 65 who lack access to supplemental insurance are forced to spend down their assets to become eligible for Medicaid coverage. This is financially devastating for these individuals and, in the end, will cost the State – and its taxpayers – more money.
Medigap is a supplemental insurance policy option specifically for Medicare beneficiaries designed to fill the “gaps” in Original Medicare coverage to provide greater financial stability and security for patients. Patients with access to Medigap select an available plan option offered by commercial insurers and pay a fixed monthly premium amount that helps cover and cap their out-of-pocket co-pays and deductibles that Medicare alone doesn’t cover. The problem, however, is that Medigap coverage isn’t currently accessible to all ESRD patients who are on Medicare.
When Medigap plans were first introduced, Congress only guaranteed issue of these plans to traditional Medicare beneficiaries (those age 65 and older who are enrolled in Medicare Parts A and B) without consumer protections and did not extend this protection to disability and ESRD patients who obtain Medicare coverage prior to age 65. Without a federal mandate to extend coverage to all Medicare-eligible beneficiaries regardless of age, states are left to determine their own Medigap policy for disability and ESRD patients under age 65. People on dialysis face serious financial struggles and difficulty accessing kidney transplantation in areas where Medigap coverage is not accessible. That’s why DPC continues to advocate for every person on dialysis to be able to purchase affordable and nondiscriminatory Medigap coverage regardless of age.
Related Information
Georgia Medigap Legislation Passes First Hurdle
On February 24, HB 323 was unanimously approved by the Health Committee of the Georgia House of Representatives. Sponsored by State Representative Karen Mathiak (R-82), this legislation will provide affordable access to Medigap coverage to [...]
Building Momentum: DPC’s Growing Patient Ambassador Network
By Yolonda Brisbane, DPC Grassroots Manager Since I began my role as Grassroots Manager for Dialysis Patient Citizens (DPC) in April 2022, I’ve had the privilege of witnessing the growth of something truly special—the Patient [...]
Indiana Governor Signs Affordable Medigap Access Legislation
In a major victory for under-age 65 dialysis patients in Indiana, Governor Eric Holcomb signed SB 215 in a formal bill signing ceremony on August 15, 2024. Attending this ceremonial bill signing was DPC [...]
DPC Advocates for Dialysis Patients at National Conference of State Legislators Summit
State legislators from across the nation convened in Louisville, Kentucky August 5-8 for the 50th National Conference of State Legislators Summit. As part of DPCs ongoing work in the states, DPC was on hand [...]
State Advocacy Update – Council of State Governments Meetings
DPC’s two State Advocacy Directors have been busy advocating for dialysis patients this summer. Pamela Zielske, DPC’s Western Region Advocacy Director, attended the 77th Council of State Governments Annual Meeting in Portland, Oregon earlier [...]
Action Alert: H.R. 5027/S. 4469 – The Chronic Kidney Disease Improvement in Research and Treatment Act
The Chronic Kidney Disease Improvement in Research and Treatment Act (H.R. 5027/S. 4469) sets the stage for the future of kidney care. Representatives Carol Miller (R-WV) and Terri Sewell (D-AL) re-introduced the bill in the [...]
